ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

Smokeless Tobacco Consensus Conference Slates in Health Risks

August 16, 1985

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

Wittes, Group Chairmen Agree On Payment Per Case, Other Methods To Increase Patient Accrual

August 21, 1987

OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million

December 8, 1978